Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure

Abstract Aims We aimed to test whether the endogenous filtration markers serum creatinine or cystatin C and equation‐based estimates of glomerular filtration rate (GFR) based on these markers appropriately reflect changes of measured GFR in patients with acute heart failure. Methods In this prospect...

Full description

Bibliographic Details
Main Authors: Jutta S. Swolinsky, Niklas P. Nerger, David M. Leistner, Frank Edelmann, Fabian Knebel, Enkhtuvshin Tuvshinbat, Caroline Lemke, Robert Roehle, Michael Haase, Maria Rosa Costanzo, Geraldine Rauch, Veselin Mitrovic, Edis Gasanin, Daniel Meier, Peter A. McCullough, Kai‐Uwe Eckardt, Bruce A. Molitoris, Kai M. Schmidt‐Ott
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.13404
id doaj-55af40f7e153483f8a72d7edbb88e7e4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jutta S. Swolinsky
Niklas P. Nerger
David M. Leistner
Frank Edelmann
Fabian Knebel
Enkhtuvshin Tuvshinbat
Caroline Lemke
Robert Roehle
Michael Haase
Maria Rosa Costanzo
Geraldine Rauch
Veselin Mitrovic
Edis Gasanin
Daniel Meier
Peter A. McCullough
Kai‐Uwe Eckardt
Bruce A. Molitoris
Kai M. Schmidt‐Ott
spellingShingle Jutta S. Swolinsky
Niklas P. Nerger
David M. Leistner
Frank Edelmann
Fabian Knebel
Enkhtuvshin Tuvshinbat
Caroline Lemke
Robert Roehle
Michael Haase
Maria Rosa Costanzo
Geraldine Rauch
Veselin Mitrovic
Edis Gasanin
Daniel Meier
Peter A. McCullough
Kai‐Uwe Eckardt
Bruce A. Molitoris
Kai M. Schmidt‐Ott
Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure
ESC Heart Failure
Acute heart failure
Worsening kidney function
Acute kidney injury
CKD‐EPI formula
Measured GFR
Visible fluorescent injectate
author_facet Jutta S. Swolinsky
Niklas P. Nerger
David M. Leistner
Frank Edelmann
Fabian Knebel
Enkhtuvshin Tuvshinbat
Caroline Lemke
Robert Roehle
Michael Haase
Maria Rosa Costanzo
Geraldine Rauch
Veselin Mitrovic
Edis Gasanin
Daniel Meier
Peter A. McCullough
Kai‐Uwe Eckardt
Bruce A. Molitoris
Kai M. Schmidt‐Ott
author_sort Jutta S. Swolinsky
title Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure
title_short Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure
title_full Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure
title_fullStr Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure
title_full_unstemmed Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failure
title_sort serum creatinine and cystatin c‐based estimates of glomerular filtration rate are misleading in acute heart failure
publisher Wiley
series ESC Heart Failure
issn 2055-5822
publishDate 2021-08-01
description Abstract Aims We aimed to test whether the endogenous filtration markers serum creatinine or cystatin C and equation‐based estimates of glomerular filtration rate (GFR) based on these markers appropriately reflect changes of measured GFR in patients with acute heart failure. Methods In this prospective cohort study of 50 hospitalized acute heart failure patients undergoing decongestive therapy, we applied an intravenous visible fluorescent injectate (VFI), consisting of a low molecular weight component to measure GFR and a high molecular weight component to correct for measured plasma volume. Thirty‐eight patients had two sequential GFR measurements 48 h apart. The co‐primary endpoints of the study were safety of VFI and plasma stability of the high molecular weight component. A key secondary endpoint was to compare changes in measured GFR (mGFR) to changes of serum creatinine, cystatin C and estimated GFR. Results VFI‐based GFR measurements were safe and consistent with plasma stability of the high molecular weight component and glomerular filtration of the low molecular weight component. Filtration marker‐based point estimates of GFR, when compared with mGFR, provided only moderate correlation (Pearson's r, range 0.80–0.88, depending on equation used), precision (r2, range 0.65–0.78) and accuracy (56%–74% of estimates scored within 30% of mGFR). Correlations of 48‐h changes GFR estimates and changes of mGFR were significant (P < 0.05) but weak (Pearson's r, range 0.35–0.39). Observed decreases of eGFR by more than 15% had a low sensitivity (range 38%–46%, depending on equation used) in detecting true worsening mGFR, defined by a >15% decrease in mGFR. Conclusions In patients hospitalized for acute heart failure, serum creatinine‐ and cystatin C‐based predictions performed poorly in detecting actual changes of GFR. These data challenge current clinical strategies to evaluate dynamics of kidney function in acute heart failure.
topic Acute heart failure
Worsening kidney function
Acute kidney injury
CKD‐EPI formula
Measured GFR
Visible fluorescent injectate
url https://doi.org/10.1002/ehf2.13404
work_keys_str_mv AT juttasswolinsky serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT niklaspnerger serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT davidmleistner serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT frankedelmann serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT fabianknebel serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT enkhtuvshintuvshinbat serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT carolinelemke serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT robertroehle serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT michaelhaase serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT mariarosacostanzo serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT geraldinerauch serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT veselinmitrovic serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT edisgasanin serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT danielmeier serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT peteramccullough serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT kaiuweeckardt serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT bruceamolitoris serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
AT kaimschmidtott serumcreatinineandcystatincbasedestimatesofglomerularfiltrationratearemisleadinginacuteheartfailure
_version_ 1721265363371425792
spelling doaj-55af40f7e153483f8a72d7edbb88e7e42021-07-28T18:55:36ZengWileyESC Heart Failure2055-58222021-08-01843070308110.1002/ehf2.13404Serum creatinine and cystatin C‐based estimates of glomerular filtration rate are misleading in acute heart failureJutta S. Swolinsky0Niklas P. Nerger1David M. Leistner2Frank Edelmann3Fabian Knebel4Enkhtuvshin Tuvshinbat5Caroline Lemke6Robert Roehle7Michael Haase8Maria Rosa Costanzo9Geraldine Rauch10Veselin Mitrovic11Edis Gasanin12Daniel Meier13Peter A. McCullough14Kai‐Uwe Eckardt15Bruce A. Molitoris16Kai M. Schmidt‐Ott17Department of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyDepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyDepartment of Internal Medicine and Cardiology Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Campus Benjamin Franklin Berlin GermanyClinical Research Unit Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin Berlin GermanyDepartment of Cardiology and Angiology Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Campus Mitte Berlin GermanyDepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyDepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyClinical Research Unit Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin Berlin GermanyFaculty of Medicine Otto von‐Guericke‐University Magdeburg Magdeburg GermanyAdvocate Heart Institute Naperville IL USAClinical Research Unit Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin Berlin GermanyDepartment of Cardiology Kerckhoff Klinik Bad Nauheim GermanyDepartment of Cardiology Kerckhoff Klinik Bad Nauheim GermanyFAST BioMedical Indianapolis IN USABaylor University Medical Center, Baylor Heart and Vascular Hospital Baylor Heart and Vascular Institute Dallas TX USADepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanySchool of Medicine Indiana University Indianapolis IN USADepartment of Nephrology and Medical Intensive Care Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin GermanyAbstract Aims We aimed to test whether the endogenous filtration markers serum creatinine or cystatin C and equation‐based estimates of glomerular filtration rate (GFR) based on these markers appropriately reflect changes of measured GFR in patients with acute heart failure. Methods In this prospective cohort study of 50 hospitalized acute heart failure patients undergoing decongestive therapy, we applied an intravenous visible fluorescent injectate (VFI), consisting of a low molecular weight component to measure GFR and a high molecular weight component to correct for measured plasma volume. Thirty‐eight patients had two sequential GFR measurements 48 h apart. The co‐primary endpoints of the study were safety of VFI and plasma stability of the high molecular weight component. A key secondary endpoint was to compare changes in measured GFR (mGFR) to changes of serum creatinine, cystatin C and estimated GFR. Results VFI‐based GFR measurements were safe and consistent with plasma stability of the high molecular weight component and glomerular filtration of the low molecular weight component. Filtration marker‐based point estimates of GFR, when compared with mGFR, provided only moderate correlation (Pearson's r, range 0.80–0.88, depending on equation used), precision (r2, range 0.65–0.78) and accuracy (56%–74% of estimates scored within 30% of mGFR). Correlations of 48‐h changes GFR estimates and changes of mGFR were significant (P < 0.05) but weak (Pearson's r, range 0.35–0.39). Observed decreases of eGFR by more than 15% had a low sensitivity (range 38%–46%, depending on equation used) in detecting true worsening mGFR, defined by a >15% decrease in mGFR. Conclusions In patients hospitalized for acute heart failure, serum creatinine‐ and cystatin C‐based predictions performed poorly in detecting actual changes of GFR. These data challenge current clinical strategies to evaluate dynamics of kidney function in acute heart failure.https://doi.org/10.1002/ehf2.13404Acute heart failureWorsening kidney functionAcute kidney injuryCKD‐EPI formulaMeasured GFRVisible fluorescent injectate